NCT01118910

Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo

• Status: Completed
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Image Dermatology P.C. · Academic / Other
• Sex: All
• Age: 12 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.

Detailed description

Intertrigo is an inflammatory condition of skin folds, induced or aggravated by heat, moisture, maceration, friction, or lack of air circulation. It is typically chronic with insidious onset of itching, burning, and stinging within the affected skin folds. Intertrigo frequently worsened or colonized by infection, which most commonly is candidal but also may be bacterial, fungal, or viral. The etiology of diaper dermatitis shows significant overlap with that of intertrigo. Vusion ointment, a highly effective treatment for diaper dermatitis, has been used by physicians for the treatment of intertrigo; however, there is a paucity of data in the literature regarding the use of Vusion ointment in this indication. This study is the first to formally investigate the efficacy and safety of Vusion ointment for the treatment of intertrigo.

Conditions

• Intertrigo

Interventions

Type	Name	Description
DRUG	Vusion	Vusion will be applied to areas of intertrigo

Timeline

• Start date: 2010-04-01
• Primary completion: 2010-11-01
• Completion: 2011-05-01
• First posted: 2010-05-07
• Last updated: 2011-08-04

Locations

1 site across 1 country: United States